Anders Forss

584 total citations
33 papers, 196 citations indexed

About

Anders Forss is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Anders Forss has authored 33 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 20 papers in Genetics and 13 papers in Surgery. Recurrent topics in Anders Forss's work include Inflammatory Bowel Disease (19 papers), Microscopic Colitis (19 papers) and Eosinophilic Esophagitis (7 papers). Anders Forss is often cited by papers focused on Inflammatory Bowel Disease (19 papers), Microscopic Colitis (19 papers) and Eosinophilic Esophagitis (7 papers). Anders Forss collaborates with scholars based in Sweden, United States and Switzerland. Anders Forss's co-authors include Jonas F. Ludvigsson, Ola Olén, Jonas Halfvarson, Pär Myrelid, Björn Roelstraete, David Bergman, Mark Clements, Åsa H. Everhov, Caroline Nordenvall and Gilaad G. Kaplan and has published in prestigious journals such as Gastroenterology, PLoS Medicine and The American Journal of Gastroenterology.

In The Last Decade

Anders Forss

23 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Forss Sweden 8 141 138 78 28 21 33 196
Keith Friedenberg United States 5 108 0.8× 76 0.6× 62 0.8× 41 1.5× 28 1.3× 7 186
Giulia D’Arcangelo Italy 10 217 1.5× 165 1.2× 108 1.4× 12 0.4× 19 0.9× 27 279
Claire Bewshea United Kingdom 8 165 1.2× 98 0.7× 55 0.7× 17 0.6× 28 1.3× 30 219
María Josefina Etchevers Spain 6 193 1.4× 158 1.1× 92 1.2× 14 0.5× 11 0.5× 10 218
Fabián Juliao Baños Colombia 5 164 1.2× 130 0.9× 81 1.0× 20 0.7× 11 0.5× 38 209
Ivan Bunganič Hungary 6 109 0.8× 95 0.7× 71 0.9× 42 1.5× 11 0.5× 9 179
I.A. Mouzas Greece 4 250 1.8× 220 1.6× 93 1.2× 35 1.3× 19 0.9× 7 305
Jean-Eric Labérenne France 2 235 1.7× 199 1.4× 108 1.4× 18 0.6× 20 1.0× 3 254
An Outtier Belgium 6 149 1.1× 102 0.7× 54 0.7× 15 0.5× 17 0.8× 22 178
CS Probert United Kingdom 4 251 1.8× 210 1.5× 107 1.4× 52 1.9× 34 1.6× 9 300

Countries citing papers authored by Anders Forss

Since Specialization
Citations

This map shows the geographic impact of Anders Forss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Forss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Forss more than expected).

Fields of papers citing papers by Anders Forss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Forss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Forss. The network helps show where Anders Forss may publish in the future.

Co-authorship network of co-authors of Anders Forss

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Forss. A scholar is included among the top collaborators of Anders Forss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Forss. Anders Forss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forss, Anders, Gabriella Bröms, David Bergman, et al.. (2025). Microscopic Colitis and Risk of Venous Thromboembolism: A Nationwide Matched Cohort Study. The American Journal of Gastroenterology. 120(12). 2867–2876.
2.
Zingone, Fabiana, Cristina Canova, Anders Forss, et al.. (2025). Prevalence of Celiac Disease in Patients With Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis. Liver International. 45(9). e70293–e70293.
3.
Bröms, Gabriella, Anders Forss, Johan Askling, et al.. (2025). Adult-onset inflammatory bowel disease and the risk of venous thromboembolism – a Swedish nationwide cohort study 2007–2021. Scandinavian Journal of Gastroenterology. 60(6). 526–535.
4.
Ebrahimi, Ramin, Fahim Ebrahimi, Jan Hendrik Niess, et al.. (2025). Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study. Alimentary Pharmacology & Therapeutics. 61(12). 1904–1912. 1 indexed citations
5.
Khalili, Hamed, et al.. (2025). Statin Use is Associated with a Less Severe Disease Course In Inflammatory Bowel Disease: A Nationwide Cohort Study 2006-2020. Inflammatory Bowel Diseases. 31(10). 2787–2797. 3 indexed citations
6.
Vujasinović, Miroslav, Patrick Maisonneuve, Anders Forss, et al.. (2025). Pancreatic Exocrine Insufficiency Is Not Uncommon in Celiac Disease: A Systematic Review and Meta‐Analysis. United European Gastroenterology Journal. 13(7). 1107–1115.
7.
Myrelid, Pär, Jonas F. Ludvigsson, Anders Forss, et al.. (2025). Substantial Reduction of Systemic Corticosteroid Use After Primary Ileocaecal Resection in Swedish Patients With Crohn's Disease: A Population‐Based Cohort Study. Alimentary Pharmacology & Therapeutics. 61(10). 1649–1661.
8.
Axelrad, Jordan E., Anders Forss, Karl Mårild, et al.. (2025). Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study. Journal of Crohn s and Colitis. 20(2).
9.
Forss, Anders, et al.. (2024). Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab: a systematic review. Scandinavian Journal of Gastroenterology. 59(7). 821–829. 6 indexed citations
10.
Atia, Ohad, Amir Ben‐Tov, Mehdi Osooli, et al.. (2024). The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide Cohorts. Journal of Crohn s and Colitis. 18(8). 1241–1249. 5 indexed citations
11.
Ludvigsson, Jonas F., Anders Forss, Anne‐Laure Faucon, et al.. (2024). Risk of Kidney Failure in Patients With Inflammatory Bowel Disease Undergoing Colectomy: A Nationwide Cohort Study. Clinical Gastroenterology and Hepatology. 22(11). 2291–2298.e17. 3 indexed citations
12.
Forss, Anders, Marcus Thuresson, Jiangwei Sun, et al.. (2024). Diverticular disease and risk of incident major adverse cardiovascular events: a nationwide matched cohort study. European Heart Journal - Quality of Care and Clinical Outcomes. 11(4). 415–423. 1 indexed citations
13.
Ebrahimi, Fahim, Ramin Ebrahimi, Hannes Hagström, et al.. (2024). Risk of Major Adverse Cardiovascular Outcomes in Families With MASLD: A Population-Based Multigenerational Cohort Study. Circulation Cardiovascular Quality and Outcomes. 17(11). e010912–e010912. 2 indexed citations
14.
Eriksson, Carl, Jiangwei Sun, Gabriella Bröms, et al.. (2024). Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study. Alimentary Pharmacology & Therapeutics. 59(9). 1122–1133. 6 indexed citations
15.
Hellgren, Karin, et al.. (2024). Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus Science & Medicine. 11(1). e001106–e001106. 1 indexed citations
16.
Ebrahimi, Fahim, Tracey G. Simon, Hannes Hagström, et al.. (2023). Antibiotic use and development of nonalcoholic fatty liver disease: A population‐based case–control study. Liver International. 43(10). 2186–2197. 8 indexed citations
17.
Sun, Jiangwei, Björn Roelstraete, Emma Svennberg, et al.. (2023). Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study. PLoS Medicine. 20(10). e1004305–e1004305. 11 indexed citations
18.
Forss, Anders, David Bergman, Björn Roelstraete, et al.. (2023). Patients With Microscopic Colitis Are at Higher Risk of Major Adverse Cardiovascular Events: A Matched Cohort Study. Clinical Gastroenterology and Hepatology. 21(13). 3356–3364.e9. 9 indexed citations
19.
Hedin, Charlotte, Anders Forss, Charlotte Söderman, et al.. (2022). Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register. United European Gastroenterology Journal. 10(7). 631–639. 29 indexed citations
20.
Forss, Anders, Mark Clements, Pär Myrelid, et al.. (2022). Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease. Digestive Diseases and Sciences. 68(1). 65–76. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Friedenberg Breakdown of academic impact, for papers by Giulia D’Arcangelo Breakdown of academic impact, for papers by Claire Bewshea Breakdown of academic impact, for papers by María Josefina Etchevers Breakdown of academic impact, for papers by Fabián Juliao Baños Breakdown of academic impact, for papers by Ivan Bunganič Breakdown of academic impact, for papers by I.A. Mouzas Breakdown of academic impact, for papers by Jean-Eric Labérenne Breakdown of academic impact, for papers by An Outtier Breakdown of academic impact, for papers by CS Probert
Rankless by CCL
2026